ImmunoGen Inc. (IMGN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark J. Enyedy
Employees:
110
830 WINTER ST, WALTHAM, MA 02451
(781)895-0600

ImmunoGen, Inc. develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer.

Data derived from most recent annual or quarterly report
Market Cap 4.023 Billion Shares Outstanding248.943 Million Avg 30-day Volume 5.435 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0.1
Price to Revenue13.7362 Debt to Equity0.1284 EBITDA-78.459 Million
Price to Book Value7.0348 Operating Margin-27.879399999999997 Enterprise Value3.417 Billion
Current Ratio5.695 EPS Growth0.299 Quick Ratio5.49
1 Yr BETA 0.6809 52-week High/Low 20.69 / 3.61 Profit Margin-25.5627
Operating Cash Flow Growth8.1624 Free Cash Flow to Firm (FCFF) TTM -215.808 Million Free Cash Flow to Equity (FCFE) TTM-58.019 Million
Altman Z-Score7.1406
View SEC Filings from IMGN instead.

View recent insider trading info

ImmunoGen Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IMGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-17 by WINGROVE THERESA
  • 4: filed on 2023-11-17 by COEN STACY ANN
  • 4: filed on 2023-11-08 by WINGROVE THERESA
  • 4: filed on 2023-11-08 by LENTINI RENEE
  • 4: filed on 2023-11-08 by WALLACE RICHARD JOHN
  • 4: filed on 2023-11-01 by GOLDBERG MARK ALAN
  • 4: filed on 2023-10-18 by WINGROVE THERESA
  • 4: filed on 2023-10-02 by THACKRAY HELEN M.
  • 4: filed on 2023-10-02 by ARBUCKLE STUART A
  • 4: filed on 2023-10-02 by GOLDBERG MARK ALAN

    • Events (8k)

  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-16:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-05:
  • 144: filed on 2023-08-02:
  • 144: filed on 2023-08-02:
  • 144: filed on 2023-08-02:
  • 144: filed on 2023-08-03:
  • 144: filed on 2023-08-04:
  • 144: filed on 2023-08-04:
  • 144: filed on 2023-08-09:
  • 144: filed on 2023-08-14:
  • 144: filed on 2023-08-15:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    706.4 Thousand total shares from 7 transactions

    Exercise Derivative Conversion (M)

    637.4 Thousand total shares from 20 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WINGROVE THERESA SVP OF REGULATORY AFFAIRS

    • Officer
    		 2,811 2023-11-15 7

    COEN STACY ANN SVP & CHIEF BUSINESS OFFICER

    • Officer
    		 36,966 2023-11-15 6

    WALLACE RICHARD JOHN

    • Director
    		 10,000 2023-11-07 2

    LENTINI RENEE VP & PRIN ACCTG OFFICER

    • Officer
    		 0 2023-11-06 7

    GOLDBERG MARK ALAN

    • Director
    		 60,151 2023-10-30 6

    ARBUCKLE STUART A

    • Director
    		 4,939 2023-09-29 4

    THACKRAY HELEN M.

    • Director
    		 2,822 2023-09-29 4

    MITCHELL DEAN J

    • Director
    		 152,667 2023-09-22 3

    WHITE LAUREN SVP, CFO AND PFO

    • Officer
    		 0 2023-09-18 2

    MCCLUSKI STEPHEN C

    • Director
    		 0 2023-09-13 2

    PETERSON KRISTINE

    • Director
    		 0 2023-09-13 2

    ENYEDY MARK J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 553,270 2023-08-02 3

    BERKENBLIT ANNA SVP & CHIEF MEDICAL OFFICER

    • Officer
    		 113,935 2023-06-30 3

    MCCAIN TRACEY L

    • Director
    		 0 2023-06-14 2

    KALOFONOS ISABEL SVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2023-04-28 2

    VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS

    • Officer
    		 0 2022-12-29 2

    CHAR DANIEL SVP & CHIEF LEGAL OFFICER

    • Officer
    		 401,000 2022-11-30 1

    HARRINGTON-SMITH KRISTEN SVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 75,000 2022-11-15 0

    ALTSCHULLER SUSAN SVP AND CFO

    • Officer
    		 123,750 2022-05-20 0

    RYLL THOMAS SVP, TECHNICAL OPERATIONS

    • Officer
    		 84,714 2021-06-30 0

    FOSTER DAVID G V.P.-FIN., PRIN. ACCTG. OFF.

    • Officer
    		 37,912 2020-12-31 0

    BARROWS CRAIG EXECUTIVE VP, GENERAL COUNSEL

    • Officer
    		 145,275 2020-02-24 0

    MCKEE BLAINE H. EVP & CHIEF BUSINESS OFFICER

    • Officer
    		 5,230 2019-07-01 0

    GREGORY RICHARD J. EXECUTIVE VP & CSO

    • Officer
    		 199,413 2019-02-22 0

    JOHNSTON DAVID BRANNON CHIEF FINANCIAL OFFICER

    • Officer
    		 270,690 2018-06-06 0

    JUNIUS DANIEL M

    • Director
    		 184,987 2018-03-16 0

    PIEN HOWARD H

    • Director
    		 0 2017-12-31 0

    VILLAFRANCA JOSEPH J

    • Director
    		 0 2017-12-31 0

    WILLIAMS PETER J. VP, BUSINESS DEVELOPMENT

    • Officer
    		 50,620 2017-02-23 0

    LAMBERT JOHN EXECUTIVE VICE PRESIDENT

    • Officer
    		 120,521 2016-11-02 0

    POOLE SANDRA EXECUTIVE VP, TECH OPERATIONS

    • Officer
    		 0 2016-10-19 0

    MORRIS CHARLES Q EXECUTIVE VP & CDO

    • Officer
    		 0 2016-07-18 0

    HARRISON ELLIE VP & CHIEF HR OFFICER

    • Officer
    		 0 2016-07-18 0

    ONETTO NICOLE

    • Director
    		 0 2015-11-10 0

    O'LEARY JAMES J VICE PRESIDENT

    • Officer
    		 0 2014-07-17 0

    PERRY GREGORY D CHIEF FINANCIAL OFFICER

    • Officer
    		 56,665 2013-09-10 0

    SKALETSKY MARK B

    • Director
    		 0 2012-11-13 0

    SAYARE MITCHEL

    • Director
    		 383,136 2011-07-29 0

    CARTER DAVID WARREN

    • Director
    		 0 2010-11-16 0

    CADDEN SUZANNE VP, REGULATORY & QUALITY

    • Officer
    		 0 2009-12-17 0

    SAMANA CAPITAL, L.P.

    MORTON HOLDINGS, INC.

    KORSANT PHILIP B

    • 10% Owner
    		 No longer subject to file 2009-07-31 0

    ZIFF ASSET MANAGEMENT LP

    PBK HOLDINGS INC

    KORSANT PHILIP B

    ZBI EQUITIES, L.L.C.

    • 10% Owner
    		 9,046,200 2008-06-20 0

    TAGLIAMONTE JOHN VP, BUSINESS DEVELOPMENT

    • Officer
    		 0 2008-06-11 0

    RYAN PAULINE JEN SVP CORPORATE DEVLP & OPS

    • Officer
    		 60,000 2007-06-12 0

    BLATTLER WALTER EXECUTIVE VICE PRESIDENT

    • FORMER EXECUTIVE VP
    		 148,400 2007-04-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-17 M 2,200 $4.92 a 39,166 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-17 S 78,223 $16.05 d 36,966 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-17 M 76,023 d 76,787 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-17 M 76,023 $7.69 a 115,189 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-17 M 2,200 d 48,823 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-16 M 900 $7.69 a 41,066 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-16 M 900 d 152,810 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-16 M 3,200 $4.92 a 40,166 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-16 M 3,200 d 51,023 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-16 S 4,100 $16.01 d 36,966 direct yes 1.8072 1.8072 2 0.0 1

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-17 19:53:59 -0500 2023-11-15 M 166,725 d 41,681 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-15 M 5,300 $7.69 a 63,252 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-15 M 5,300 d 153,710 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-15 M 20,986 $4.92 a 57,952 direct yes 1.8072 1.8072 2 0.0 1

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-15 M 20,986 d 54,223 direct yes

    COEN STACY ANN - Officer SVP & CHIEF BUSINESS OFFICER

    		2023-11-17 19:52:55 -0500 2023-11-15 S 26,286 $16.01 d 36,966 direct yes 1.8072 1.8072 2 0.0 1

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-17 19:53:59 -0500 2023-11-15 M 166,725 $4.55 a 169,536 direct yes 1.8072 1.8072 2 0.0 1

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-17 19:53:59 -0500 2023-11-15 S 166,725 $15.85 d 2,811 direct yes 1.8072 1.8072 2 0.0 1

    WALLACE RICHARD JOHN - Director

    		2023-11-08 17:53:58 -0500 2023-11-07 M 10,000 d 0 direct

    WALLACE RICHARD JOHN - Director

    		2023-11-08 17:53:58 -0500 2023-11-07 M 10,000 $14.70 a 10,000 direct 0.1357 5.7666 6.9199 4 0.0 1

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-08 17:56:39 -0500 2023-11-07 M 19,517 d 140,483 direct yes

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-08 17:56:39 -0500 2023-11-07 S 19,517 $16.66 d 2,811 direct yes 0.1357 5.7666 6.9199 4 0.0 1

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-11-08 17:56:39 -0500 2023-11-07 M 19,517 $10.65 a 22,328 direct yes 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 55,550 d 25,250 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 S 219,545 $15.29 d 0 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 2,619 $2.68 a 110,636 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 2,619 d 0 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 4,024 $6.98 a 152,033 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 4,024 d 12,625 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 9,000 $10.79 a 108,017 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 9,000 d 0 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 11,962 $5.32 a 219,545 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 11,962 d 53,831 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 14,373 $5.25 a 148,009 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 14,373 d 0 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 23,000 $10.65 a 133,636 direct 0.1357 5.7666 6.9199 4 0.0 1

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 23,000 d 0 direct

    LENTINI RENEE - Officer VP & PRIN ACCTG OFFICER

    		2023-11-08 17:55:47 -0500 2023-11-06 M 55,550 $7.69 a 207,583 direct 0.1357 5.7666 6.9199 4 0.0 1

    GOLDBERG MARK ALAN - Director

    		2023-11-01 17:59:27 -0400 2023-10-30 M 10,000 d 0 direct yes

    GOLDBERG MARK ALAN - Director

    		2023-11-01 17:59:27 -0400 2023-10-30 M 10,000 $15.08 d 60,151 direct yes 5.0968 -4.9032 5.0968 2 -4.9032 6

    GOLDBERG MARK ALAN - Director

    		2023-11-01 17:59:27 -0400 2023-10-30 M 10,000 $14.70 a 70,151 direct yes 5.0968 -4.9032 5.0968 2 -4.9032 6

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-10-18 16:25:42 -0400 2023-10-16 M 33,363 d 208,406 direct

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-10-18 16:25:42 -0400 2023-10-16 M 158,641 $4.55 a 161,452 direct -3.0822 1.3014 1.3014 6 -14.6575 3

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-10-18 16:25:42 -0400 2023-10-16 M 158,641 d 63,659 direct

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-10-18 16:25:42 -0400 2023-10-16 S 192,004 $14.40 d 2,811 direct -3.0822 1.3014 1.3014 6 -14.6575 3

    WINGROVE THERESA - Officer SVP OF REGULATORY AFFAIRS

    		2023-10-18 16:25:42 -0400 2023-10-16 M 33,363 $4.55 a 194,815 direct -3.0822 1.3014 1.3014 6 -14.6575 3

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    IMMUNOGEN INC IMGN 2023-11-28 22:15:04 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 21:45:03 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 21:15:04 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 20:45:04 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 20:15:04 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 19:45:03 UTC 4.9117 0.4083 3000000
    IMMUNOGEN INC IMGN 2023-11-28 19:15:04 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 18:45:03 UTC 4.9116 0.4084 2900000
    IMMUNOGEN INC IMGN 2023-11-28 18:15:03 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 17:45:04 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 17:15:04 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 16:45:04 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 16:15:04 UTC 4.9116 0.4084 3000000
    IMMUNOGEN INC IMGN 2023-11-28 15:45:03 UTC 4.9116 0.4084 2900000
    IMMUNOGEN INC IMGN 2023-11-28 15:15:03 UTC 4.9116 0.4084 2900000
    IMMUNOGEN INC IMGN 2023-11-28 14:45:04 UTC 4.9019 0.4181 3000000
    IMMUNOGEN INC IMGN 2023-11-28 14:15:04 UTC 4.9019 0.4181 3000000
    IMMUNOGEN INC IMGN 2023-11-28 13:45:04 UTC 4.9019 0.4181 3000000
    IMMUNOGEN INC IMGN 2023-11-28 13:15:03 UTC 4.9019 0.4181 2900000
    IMMUNOGEN INC IMGN 2023-11-28 12:45:04 UTC 4.9019 0.4181 1800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund IMGN -7200.0 shares, $-40824.0 2021-09-30 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund IMGN -1915.0 shares, $-34125.3 2023-07-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund IMGN -556.0 shares, $-8823.72 2023-09-30 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Strategic Equity Fund IMGN -3208.0 shares, $-50910.96 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments